The Indian pharmaceutical sector enters the second half of 2026 with significant momentum as three major developments converge: the India-UK Comprehensive Economic Trade Agreement (CETA) taking effect on July 15,…
India's pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early…
India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…
The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…